Opinion
Video
Author(s):
A panelist discusses how pharmacists can overcome patient reluctance to shingles vaccination by transparently addressing adverse effect concerns, using multiple patient interactions to build acceptance over time, and sharing personal stories about shingles complications to help patients understand the real risks of the disease.
The primary challenge in shingles vaccine acceptance stems from patient concerns about side effects, which can be effectively addressed through up-front, honest discussions about manageable common reactions. Success often requires multiple patient interactions, as initial conversations serve as introductions to vaccine education rather than immediate decision points. Pharmacists should document patient refusals and implement recurring reminder systems, consistently reinforcing the importance of vaccination at every subsequent interaction, whether for prescription pickups, other vaccines, or health screenings.
Personal stories and real-world examples significantly impact patient decision-making, helping them visualize the consequences of shingles and connect the illness to people they may know. When patients understand the complications and long-term effects of shingles, they often reconsider their initial refusal. This human element transforms abstract medical recommendations into relatable, urgent health decisions that resonate with patients’ lived experiences and concerns.
When patients express desire to consult their physicians before vaccination, pharmacists should view this as engagement rather than rejection, demonstrating the patient’s thoughtful approach to health care decisions. The COVID-19 pandemic elevated pharmacy roles in vaccination efforts, shifting patient perceptions and establishing pharmacist expertise in immunization. Pharmacists can leverage state registries to identify coverage gaps, confidently demonstrating their vaccine knowledge while showing patients objective evidence of their immunization needs beyond personal recommendations.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.